Found: 8
Select item for more details and to access through your institution.
New-onset IgG autoantibodies in hospitalized patients with COVID-19.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-25509-3
- By:
- Publication type:
- Article
Protective efficacy of influenza group 2 hemagglutinin stem-fragment immunogen vaccines.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0036-2
- By:
- Publication type:
- Article
Heterogeneity in IgG-CD16 signaling in infectious disease outcomes.
- Published in:
- Immunological Reviews, 2022, v. 309, n. 1, p. 64, doi. 10.1111/imr.13109
- By:
- Publication type:
- Article
CD8<sup>+</sup> T cells specific for conserved coronavirus epitopes correlate with milder disease in patients with COVID-19.
- Published in:
- Science Immunology, 2021, v. 6, n. 61, p. 1, doi. 10.1126/sciimmunol.abg5669
- By:
- Publication type:
- Article
Differential Peripheral Blood Glycoprotein Profiles in Symptomatic and Asymptomatic COVID-19.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 3, p. 553, doi. 10.3390/v14030553
- By:
- Publication type:
- Article
Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multiomics study.
- Published in:
- eLife, 2022, p. 1, doi. 10.7554/eLife.77943
- By:
- Publication type:
- Article
Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 635, p. 1, doi. 10.1126/scitranslmed.abm7853
- By:
- Publication type:
- Article
Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 634, p. 1, doi. 10.1126/scitranslmed.abn7842
- By:
- Publication type:
- Article